Last reviewed · How we verify

NCT05970653

Effect of RIC on Cerebral Autoregulation in Patients Undergoing Cerebrovascular Stent Implantation

Status unknown NA Last updated 28 February 2024
What this trial tests

NA trial testing Remote ischemic conditioning in Remote Ischemic Conditioning in 104 participants. Status unknown.

Timeline
2 August 2023
Primary endpoint
31 May 2024
31 August 2024

Quick facts

Lead sponsorYi Yang
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment104
Start date2 August 2023
Primary completion31 May 2024
Estimated completion31 August 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yi Yang — full company profile →

Who can join

18 and older, any sex, with Remote Ischemic Conditioning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effect of remote ischemic conditioning on cerebral autoregulation in patients undergoing cerebrovascular stent implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Remote ischemic conditioning

Trials testing the same drug.

Other recruiting trials for Remote Ischemic Conditioning

Currently open trials in the same condition.

Other Yi Yang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05970653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing